Bortezomib in Patients With Metastatic Castration-Resistant Prostate Cancer With PTEN Deletion
Bortezomib in Patients With Metastatic Castration-Resistant Prostate Cancer With PTEN Deletion
Active, not recruiting · NCT06029998 · Registry updated 2026-07-07Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Bortezomib in Patients With Metastatic Castration-Resistant Prostate Cancer With PTEN Deletion | Metastatic Castration-resistant Prostate Cancer | Active, not recruiting | Phase 2 | 2026-07-07 | NCT06029998 |
1 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| University of Utah | 319 |
1 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Huntsman Cancer Institute/University of Utah | Salt Lake City | United States | 249 |